Preserved antilipolytic insulin action is associated with a less atherogenic plasma lipid profile in healthy centenarians

Journal of the American Geriatrics Society

Volumn 45, Issue 12, 1997, Pages 1504-1509

  Paolisso, Giuseppe ^a,c   Gambardella, Antonio ^a   Ammendola, Stefania ^b   Tagliamonte, Maria Rosaria ^a   Rizzo, Maria Rosaria ^b   Capurso, Antonio ^a   Varricchio, Michele ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Servizio di Astanteria Medica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE;

EID: 0030856319     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03203.x     Document Type: Article

References (30)

1. De Fronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-191.
2. Williams B. Insulin resistance: The shape of the thing to come. Lancet 1994;334:521-524.
3. Harris T, Cook EF, Kannel WB, Goldman MPH. Proportional hazard analysis of risk factors for coronary heart diseases in individuals aged 65 or older. The Framingham Heart Study. J Am Geriatr Soc 1988;35:1023-1027.
4. Mykkanen L, Kuusisto L, Haffner S et al. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Atheroscler Thromb 1994;14:518-526.
5. Paolisso G, Gambardella A, Balbi V et al. Body composition, body fat distribution and resting metabolic rate in healthy centenarians. Am J Clin Nutr 1995;50:746-750.
6. Paolisso G, Gambardella A, D'Amore A et al. Glucose tolerance and insulin action in healthy centenarians. Am J Physiol (Endocrinol Metab) 1996;270:E890-896.
7. Haskel WL. Design and implementation of cardiac conditioning progress. In: Wenger NK and Hellerstein H, eds. Rehabilitation of the Coronary Patient. New York: John Wiley & Sons, 1978, pp 203-241.
8. Physical activity: The use and interpretration of anthropometry. WHO Technical Report Series, 1995.
9. Chumlea WC, Roche AF, Steinbugh MC. Estimation stature from knee height for person 60 to 90 years of age. J Am Geriatr Soc 1985;33:116-120.
10. Deurenberg P, Van der Koij E, Evers P, Hulshof V. Assessment of body composition by bioelectrical impedance in a population aged >60 years. Am J Clin Nutr 1990;51:3-6.
11. De Fronzo RA, Tobin R, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol (Endocrinol. Metab) 1979;327:E214-223.
12. Penttila I, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytic and precipitation methods for direct estimation of serum highdensity lipoprotein cholesterol. Scand J Clin Lab Invest 1981;41:353-360.
13. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-1080.
14. Wahlefeld AN. 1974. Triglycéride determination after enzymatic hydrolysis. In: Bergmeyer HV, ed. Methods of Enzymatic Analysis, 2nd Ed.. New York: Academic Press, pp 1831-1835.
15. Friedewald WT, Levy R, Fredrickson DS. Estimation of serum low density lipoprotein without the use of a preparative ultracentrifuge. Clin Chem 1972;18:499-502.
16. Miles J, Gloosoch. J, Auken J. A microfluorimetric method for the determination of free fatty acids. J Lipid Res 1983;24:95-99.
17. Howard BW. 1994. Insulin action in vivo: Insulin and lipoproteins. In: Alberti KGMM, De Fronzo RA, Zimmet P, eds. International Textbook of Diabetes Mellitus, 2nd Ed. Sussex: John Wiley & Son.
18. Glueck CJ, Levy RI, Frederickson DS. Immunoreactive insulin, glucose tolerance and carbohydrate inducibility in type II, HI, IV, and V hyperlipoproteinemia. Diabetes 1969;18:739-747.
19. Reaven GM, Lerner RL, Stern MP, Ferquher JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967;46:1756-1767.
20. Howard BW, Knowler WC, Vasquez B et al. Plasma and lipoprotein cholesterol and triglycérides in the Pima Indian population. Arteriosclerosis 1984;4:462-471.
21. Cambien FJ, Werner M, Eschwege E et al. Body mass, blood pressure, glucose and lipid: Does plasma insulin explain their relationship? Arteriosclerosis 1987;7:197-202.
22. Howard BW, Welty TK, Fabsitz RR. Risk factors for coronary heart disease and non-diabetic native Americans. Diabetes 1992;14:4-11.
23. Fontbonne A, Popz L, Eschwege E et al. Features of insulin-resistance syndrome in men from a French Carribean island. Diabetes 1992;41:1385-1389.
24. Manolio TA, Savage PJ, Burke GL. Association of fasting insulin with blood pressure and lipid in young adults. Arteriosclerosis 1990;10:430-436.
25. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223-231.
26. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: A proposal for coronary heart disease risk. Circulation 1990;82:495-506.
27. Blomhoff JP. Lipoproteins, lipases and the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol 20(suppl 8): S22-25.
28. Godstand IF, Crook D, Walton C et al. Influence of insulin resistance, secretion and clearance on serum cholesterol, triglycérides, lipoprotein cholesterol, and blood pressure in healthy men Arterioscler Thromb 1992;12:1030-1035.
29. Rändle PJ, Hales CN, Garland PB, Newsholme EA. The glucose-fatty acid cycle. Its role in insulin insensitivity and the metabolic disturbance of diabetes mellitus. Lancet 1963;I:785-789.
30. Ferrannini E, Vichi S, Beck-Nielsen H et al. Insulin sensitivity and age. Diabetes 1996;4S:947-956.